Immunity after SARS-CoV-2 infections

被引：18

作者：

Jagannathan, Prasanna ^{[1
,2
]}

Wang, Taia T. ^{[1
,2
,3
]}

机构：

[1] Stanford Univ, Dept Med, Div Infect Dis, Stanford, CA 94305 USA

[2] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA

[3] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA

来源：

NATURE IMMUNOLOGY | 2021年 / 22卷 / 05期

基金：

美国国家卫生研究院;

关键词：

D O I：

10.1038/s41590-021-00923-3

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

T cell responses probably play important roles in the control of SARS-CoV-2 infection, but they have been relatively understudied. Data now suggest that the majority of infected individuals develop robust and long-lasting T cell immunity, which has implications for the durability of immunity and future vaccine approaches.

引用

页码：539 / 540

页数：2

共 50 条

[31] Evolution of antibody immunity to SARS-CoV-2
Gaebler, Christian
Wang, Zijun
Lorenzi, Julio C. C.
Muecksch, Frauke
Finkin, Shlomo
Tokuyama, Minami
Cho, Alice
Jankovic, Mila
Schaefer-Babajew, Dennis
Oliveira, Thiago Y.
Cipolla, Melissa
Viant, Charlotte
Barnes, Christopher O.
Bram, Yaron
Breton, Gaelle
Hagglof, Thomas
Mendoza, Pilar
Hurley, Arlene
Turroja, Martina
Gordon, Kristie
Millard, Katrina G.
Ramos, Victor
Schmidt, Fabian
Weisblum, Yiska
Jha, Divya
Tankelevich, Michael
Martinez-Delgado, Gustavo
Yee, Jim
Patel, Roshni
Dizon, Juan
Unson-O'Brien, Cecille
Shimeliovich, Irina
Robbiani, Davide F.
Zhao, Zhen
Gazumyan, Anna
Schwartz, Robert E.
Hatziioannou, Theodora
Bjorkman, Pamela J.
Mehandru, Saurabh
Bieniasz, Paul D.
Caskey, Marina
Nussenzweig, Michel C.
NATURE, 2021, 591 (7851) : 639 - +
[32] Toward superhuman SARS-CoV-2 immunity?
Burton, Dennis R.
Topol, Eric J.
NATURE MEDICINE, 2021, 27 (01) : 5 - 6
[33] Immunity to SARS-CoV-2: Lessons Learned
Fergie, Jaime
Srivastava, Amit
FRONTIERS IN IMMUNOLOGY, 2021, 12
[34] SARS-CoV-2 immunity in animal models
Zhao Chen
Yaochang Yuan
Qingtao Hu
Airu Zhu
Fenghua Chen
Shu Li
Xin Guan
Chao Lv
Tian Tang
Yiyun He
Jinling Cheng
Jie Zheng
Xiaoyu Hu
Jingxian Zhao
Jincun Zhao
Jing Sun
Cellular & Molecular Immunology, 2024, 21 : 119 - 133
[35] Immunity to SARS-CoV-2 variants of concern
Altmann, Daniel M.
Boyton, Rosemary J.
Beale, Rupert
SCIENCE, 2021, 371 (6534) : 1103 - 1104
[36] T cell immunity to SARS-CoV-2
Niessl, Julia
Sekine, Takuya
Buggert, Marcus
SEMINARS IN IMMUNOLOGY, 2021, 55
[37] Breakthrough SARS-CoV-2 Infections after Vaccination in North Carolina
Uschner, Diane
Bott, Matthew
Lagarde, William H.
Keating, Joseph
Tapp, Hazel
Berry, Andrea A.
Seals, Austin L.
Munawar, Iqra
Schieffelin, John
Yukich, Joshua
Santacatterina, Michele
Gunaratne, Mihili
Fette, Lida M.
Burke, Brian
Strylewicz, Greg
Edelstein, Sharon L.
Ahmed, Amina
Miller, Kristen
Sanders, John W.
Herrington, David
Weintraub, William S.
Runyon, Michael S.
VACCINES, 2022, 10 (11)
[38] Breakthrough SARS-CoV-2 infections after vaccination: a critical review
Afshar, Zeinab Mohseni
Barary, Mohammad
Hosseinzadeh, Rezvan
Alijanpour, Amirmasoud
Hosseinzadeh, Dariush
Ebrahimpour, Soheil
Nazary, Kosar
Sio, Terence T.
Sullman, Mark J. M.
Carson-Chahhoud, Kristin
Babazadeh, Arefeh
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (05)
[39] SARS-CoV-2: from herd immunity to hybrid immunity
David Goldblatt
Nature Reviews Immunology, 2022, 22 : 333 - 334
[40] Natural immunity to SARS-CoV-2 and breakthrough infections in vaccinated and unvaccinated patients with cancer
Alessio Cortellini
Juan Aguilar-Company
Ramon Salazar
Mark Bower
Ailsa Sita-Lumsden
Andrea Plaja
Alvin J. X. Lee
Alexia Bertuzzi
Carlo Tondini
Nikolaos Diamantis
Clara Martinez-Vila
Aleix Prat
Eleanor Apthorp
Alessandra Gennari
David J. Pinato
British Journal of Cancer, 2022, 127 : 1787 - 1792

← 1 2 3 4 5 →